Tag - MBX

Feature

Microbix in talks with investors for Kinlytic relaunch

By Len Zehr Following a meeting with the FDA last month, Microbix Biosystems (TSX:MBX) is entertaining expressions of interest from potential partners to license or acquire its anti-clotting urokinase drug, which has...

May 23, 2017

Feature

Microbix validating new virology production process

By Len Zehr Microbix Biosystems (TSX:MBX) is validating a new bioreactor manufacturing platform for its world-leading line of viral and bacterial antigens and other virology products ahead of a full roll-out to...

April 5, 2016

Feature

Microbix focus squarely on LumiSort and diagnostic products

By Len Zehr So says Vaughn Embro-Pantalony, president and CEO of Microbix Biosystems (TSX:MBX), referring to the company’s livestock semen sexing technology, LumiSort, and its manufacturing of infectious disease...

April 29, 2014

Tag - MBX

Microbix in talks with investors for Kinlytic relaunch

Microbix validating new virology production process

Microbix focus squarely on LumiSort and diagnostic products

General

More